SAN DIEGO--(BUSINESS WIRE)--Inovio Biomedical Corporation (AMEX: INO) today reported financial results for the three months ended March 31, 2007.
Total revenue for the three months ended March 31, 2007 was $503,902, as compared to $697,993 for the same period in 2006. Revenue consisted of license fees, milestone payments, revenue recognized from collaborative research and development arrangements and grants.
